Earlier studies of CD4+CD25high Tregs in MS, showed similar frequencies of these cells in the peripheral blood between MS patients and healthy controls [17,18,19,28], but reported reduced suppressive activity using various functional assays [18,19,28]. Here, CD4 is linked to myeloid sarcoma.